Tim Lee | Senior Director of Investor Relations |
Jan Mikkelsen | President and Chief Executive Officer |
Scott Smith | Executive Vice President, Chief Financial Officer |
Stina Singel | Executive Vice President, Head of Clinical Development Oncology |
Joe Kelly | Senior Vice President, Head of U.S. Commercial Endocrinology |
Jessica Fye | JPMorgan |
Tazeen Ahmad | Bank of America |
David Lebowitz | Citi |
Li Watsek | Cantor |
Paul Choi | Goldman |
Derek Archila | Wells Fargo |
Josh Schimmer | Evercore |
Leland Gershell | Oppenheimer |
Andreas Argyrides | Wedbush |
Yaron Werber | Cowen |
Good day, and thank you for standing by. Welcome to the Ascendis Pharma Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session [Operator Instructions]. Please be advised that, today's conference is being recorded.